What does Sera Prognostics, Inc. do?
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18…
What is Sera Prognostics, Inc.'s P/E and P/B ratio?
Sera Prognostics, Inc. has a P/E ratio of -3.0 and a P/B ratio of 1.36.
What is Sera Prognostics, Inc.'s debt-to-equity ratio?
Sera Prognostics, Inc. has a debt-to-equity ratio of 0.05.
How much does Sera Prognostics, Inc. owe compared with what it owns?
Sera Prognostics, Inc. owes $0.32 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Sera Prognostics, Inc.'s Positivity rank?
Sera Prognostics, Inc. is ranked #2,753 of 6,774 companies globally and #973 of 4,000 in United States on PositoAI, with a Positivity Score of 21,171.
Does Sera Prognostics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Sera Prognostics, Inc..
Where can I read the latest news about Sera Prognostics, Inc.?
Recent headlines about Sera Prognostics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Sera Prognostics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Sera Prognostics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.